Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Transplantation: Methods and Outcomes, Cardiac Fibrosis and Remodeling, Cardiovascular Function and Risk Factors, and Renal Transplantation Outcomes and Treatments.
Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrow
Cognitive Function Among Heart Transplant Recipients Before and After Intravenous Iron Supplement for Iron Deficiency: Results From a Randomized, Placebo-Controlled, Double-Blind Treatment Trial.
Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction.
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial).
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis
Reduced exercise capacity is associated with left ventricular systolic dysfunction in long-term survivors of allogeneic hematopoietic stem-cell transplantation.
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes.
Circulating Levels and Prognostic Cut-Offs of sST2, hs-cTnT, and NT-proBNP in Women vs. Men with Chronic Heart Failure
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy.
NT-proBNP for Risk Prediction in Heart Failure
Prevalence of iron deficiency in heart transplant recipients.
Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation.
Symptoms of anxiety after heart transplantation and their association with mortality: A secondary analysis.
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Circulating Levels and Prognostic Value of Soluble ST2 in Heart Failure are Less Influenced by Age than N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Troponin T
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial.
Effect of high-intensity interval training in young heart transplant recipients: results from two randomized controlled trials.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations
The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure
Aquaporin-4 in the heart: expression, regulation and functional role in ischemia